Trial Profile
Use of the GnRH Agonist Leuprolide Acetate (Lupron(Registered Trademark)) to Preserve Ovarian Function in Women Undergoing Chemotherapy.
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Cetrorelix (Primary)
- Indications Infertility
- Focus Pharmacodynamics
- 20 Mar 2012 Official Title amended as reported by ClinicalTrials.gov.
- 20 Mar 2012 Status changed from completed to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 23 Jul 2010 Actual end date (Jul 2010) added as reported by ClinicalTrials.gov.